Alzamend Neuro, Inc. (ALZN)
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Alzamend Neuro, Inc.
NASDAQ:ALZNHealthcare · Biotechnology
-0.82%$1.21
AH$1.21+0.00%vs close
Mkt Cap$5.84M
Float4.7M
O/S4.83M
Vol
$ Vol
RVOL
Inst Own52.0%
SI0.7%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$8.77M
Total Assets$2.08M
Free Cash Flow-$8.07M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$733K
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:9
Nasdaq bars a compliance period at 1:250
- 1:9Reverse splitMay 12, 20259 shares → 1
- 1:10Reverse splitJul 16, 202410 shares → 1
- 1:15Reverse splitOct 31, 202315 shares → 1
Balance Sheet Details
Assets$2.08M
Liabilities$1.35M
Accounts Receivable$0
Accounts Payable$1.35M
Inventory$0
PP&E (Net)$315K
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 | 2016-04-30 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - | - | - | - | - | - | - |
| Research and Development | $3.63M | $1.41M | $6.46M | $7.45M | $5.2M | $1.31M | $1.07M | $3.7M | $323K | $275K | $0 |
| Selling, General, and Administrative | $5.14M | $3.08M | $3.48M | $7.42M | $7.12M | $3.64M | $3.35M | $1.31M | $575K | $1.27M | $69K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $8.77M | $4.5M | $9.94M | $14.87M | $12.32M | $4.95M | $4.42M | $5.01M | $898K | $1.55M | $69K |
| Operating Income (EBIT) | -$8.77M | -$4.5M | -$9.94M | -$14.87M | -$12.32M | -$4.95M | -$4.42M | -$5.01M | -$898K | -$1.55M | -$69K |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | -$7K | $18K | $10K | $8K | $47K | $159K | $0 | $0 | $0 | $0 | $0 |
| Interest Income | $1K | $0 | $0 | $0 | $0 | $2K | $14K | $146K | $33K | $22K | $0 |
| Other Income (Expense) | -$6K | -$18K | -$10K | -$8K | -$43K | -$95K | $14K | $146K | -$33K | -$22K | $0 |
| Income Before Tax (EBT) | -$8.77M | -$4.51M | -$9.95M | -$14.88M | -$12.36M | -$5.05M | -$4.41M | -$4.86M | -$932K | -$1.57M | -$69K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$8.77M | -$4.51M | -$9.95M | -$14.88M | -$12.36M | -$5.05M | -$4.41M | -$4.86M | -$932K | -$1.57M | -$69K |
| Net Income Margin | - | - | - | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||||
| EPS | -2.63 | -11.32 | -132.33 | -205.97 | -187.31 | -93.78 | -83.56 | -111.56 | -27.71 | -73.59 | 0.00 |
| Diluted EPS | -2.63 | -11.32 | -132.33 | -205.97 | -187.31 | -93.78 | -83.56 | -111.56 | -27.71 | -73.59 | 0.00 |
| Weighted Average OS | 3.34M | 398,000 | 75,000 | 72,000 | 65,000 | 53,000 | 52,000 | 43,000 | 33,000 | 21,000 | 0 |
| EBITDA | -$8.66M | -$4.45M | -$9.89M | -$14.85M | -$12.31M | -$4.95M | -$4.41M | -$5.01M | $7K | $397 | $0 |
| EBITDA Margin | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 | 2016-04-30 |
| Assets | |||||||||||
| Current Assets | |||||||||||
| Cash and Cash Equivalents | $711K | $3.95M | $376K | $5.14M | $14.06M | $1.93M | $90K | $43K | $545K | $5K | $1K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $711K | $3.95M | $376K | $5.14M | $14.06M | $1.93M | $90K | $43K | $545K | $5K | $1K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $16K | $194K | $285K | $424K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $1.05M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2K | $4K |
| Total Current Assets | $1.76M | $4.18M | $455K | $5.84M | $14.41M | $2.91M | $1.81M | $1.5M | $2.42M | $57K | $6K |
| Long-Term Assets | |||||||||||
| Property, Plant & Equipment Net | $315K | $426K | $176K | $80K | $103K | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | -$0 | $0 | $0 | $0 | $0 | $0 | $75K | $25K |
| Total Long-Term Assets | $315K | $426K | $176K | $80K | $103K | $0 | $0 | $0 | $0 | $75K | $25K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $2.08M | $4.6M | $632K | $5.92M | $14.52M | $2.91M | $1.81M | $1.5M | $2.42M | $132K | $31K |
| Liabilities | |||||||||||
| Current Liabilities | |||||||||||
| Accounts Payable | $1.35M | $635K | $2.93M | $2.87M | $1.16M | $504K | $0 | $1.1M | $90K | $126K | $3K |
| Short-Term Debt | $0 | $0 | $301K | $0 | $0 | $335K | $0 | $79 | $0 | $591K | $3K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$79 | $0 | -$0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $992K | -$79 | $0 | $0 | $25K |
| Total Current Liabilities | $1.35M | $635K | $3.23M | $2.87M | $1.16M | $900K | $992K | $1.18M | $97K | $717K | $31K |
| Long-Term Liabilities | |||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | -$0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.35M | $635K | $3.23M | $2.87M | $1.16M | $900K | $992K | $1.18M | $97K | $717K | $31K |
| Stockholders' Equity | |||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $75 | $75 | $75 | $75 | $136 | $100 |
| Common Stock | $425 | $78 | $69 | $10K | $10K | $7K | $6K | $6K | $5K | $3K | $5K |
| Retained Earnings | -$67.31M | -$58.54M | -$54.02M | -$44.07M | -$29.19M | -$16.83M | -$11.79M | -$7.38M | -$2.51M | -$1.58M | -$12K |
| Comprehensive Income & Other | $0 | $0 | $0 | -$14.88M | -$14.88M | -$14.88M | -$14.98M | -$15M | -$5K | $0 | -$3K |
| Other Stockholders' Equity | $68.04M | $62.5M | $51.43M | $47.11M | $42.54M | $18.84M | $12.6M | $7.69M | $4.83M | $993K | $7K |
| Total Equity | $733K | $3.97M | -$2.59M | $3.05M | $13.35M | $2.01M | $822K | $317K | $2.32M | -$585K | -$106 |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $2.08M | $4.6M | $632K | $5.92M | $14.52M | $2.91M | $1.81M | $1.5M | $2.42M | $132K | $31K |
| Supplementary Data | |||||||||||
| Total Debt | $0 | $0 | $301K | $0 | $0 | $335K | $63 | $79 | $0 | $591K | $3K |
| Net Debt | -$711K | -$3.95M | -$75K | -$5.14M | -$14.06M | -$1.59M | -$90K | -$43K | -$545K | $586K | $2K |
Cash Flow Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 | 2018-04-30 | 2017-04-30 | 2016-04-30 |
| Operating Activities | |||||||||||
| Net Income | -$8.77M | -$4.51M | -$9.95M | -$14.88M | -$12.36M | -$5.05M | -$4.41M | -$4.86M | -$932K | -$1.57M | -$69K |
| Depreciation & Amortization | $111K | $51K | $51K | $23K | $4K | $0 | $0 | $0 | $898K | $1.55M | $69K |
| Deferred Income Tax | $0 | $0 | $0 | -$1.71M | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $708K | $325K | $956K | $3.58M | $4.41M | $2.03M | $1.8M | $396K | $218K | $114K | $41K |
| Changes in Working Capital: | |||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $711K | $0 | $0 | $0 | $694K | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Working Capital | -$825K | -$2.44M | $671K | $2.35M | $634K | -$152K | -$299K | $1.23M | -$1.35M | -$50K | -$6K |
| Total Working Capital Change | -$114K | -$2.44M | $671K | $2.35M | $1.33M | -$152K | -$299K | $1.23M | -$1.35M | -$50K | -$6K |
| Other Non-Cash Items | $0 | $9K | $714 | $1.71M | $9K | $455K | $562K | $2.19M | -$890K | -$1.46M | -$54K |
| Net Cash from Operating | -$8.07M | -$6.57M | -$8.27M | -$8.92M | -$6.61M | -$2.71M | -$2.35M | -$1.05M | -$2.05M | -$1.42M | -$18K |
| Investing Activities | |||||||||||
| Capital Expenditures | $0 | -$300K | -$147K | $0 | -$106K | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $101K | $105K | $234K | -$400K | $0 | $0 |
| Net Cash from Investing | $0 | -$300K | -$147K | $0 | -$106K | $101K | $105K | $234K | -$400K | $0 | $0 |
| Financing Activities | |||||||||||
| Debt Repaid | - | - | - | - | - | -$402K | - | - | $364K | - | - |
| Common Stock Issuance | $795K | $2.7M | $1.25M | $200 | $18.91M | $2.1M | $2.29M | $236K | $3.62M | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $600 | $0 | $0 | -$59K | $1.95M | $2.29M | $73K | -$259K | $1.42M | $25K |
| Net Cash from Financing | $4.83M | $10.44M | $3.65M | $200 | $18.85M | $4.45M | $2.29M | $309K | $2.99M | $1.42M | $25K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$3.24M | $3.57M | -$4.76M | -$8.92M | $12.13M | $1.84M | $48K | -$502K | $540K | $4K | $7K |
| Supplementary Data | |||||||||||
| Operating Cash Flow | -$8.07M | -$6.57M | -$8.27M | -$8.92M | -$6.61M | -$2.71M | -$2.35M | -$1.05M | -$2.05M | -$1.42M | -$18K |
| Capital Expenditure | $0 | -$300K | -$147K | $0 | -$106K | $0 | $0 | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$8.07M | -$6.87M | -$8.42M | -$8.92M | -$6.72M | -$2.71M | -$2.35M | -$1.05M | -$2.05M | -$1.42M | -$18K |
| Cash at Beginning | $3.95M | $376K | $5.14M | $14.06M | $1.93M | $90K | $43K | $545K | $5K | $1K | $0 |
| Cash at End | $711K | $3.95M | $376K | $5.14M | $14.06M | $1.93M | $90K | $43K | $545K | $5K | $7K |